PROMIS-29 | Spearman’s rank correlations | Known-groups differences | Hypotheses confirmed (%) | |
---|---|---|---|---|
r ≥ 0.70 | r ≤ 0.60 | |||
Physical function | SF-12 PF SF-12 PCS | All other dissimilar constructs of legacy measures (n = 8) | Females will have lower physical function scores than males; Patients ages > 65 will have lower physical function scores than patients ages < 50; Patients with type A AD will have lower physical function scores than type B AD patients; Patients with CCI ≥ 3 will have lower physical function scores than patients with CCI < 2 | 76% |
Anxiety | GAD-2 SF-12 MCS | All other dissimilar constructs of legacy measures (n = 8) | Females will have higher anxiety scores than males; Patients with type A AD will have higher anxiety scores than Type B AD patients | 82% |
Depression | PHQ-2 SF-12 MCS | All other dissimilar constructs of legacy measures (n = 8) | Females will have higher depression scores than males; | 73% |
Fatigue | SF-12 vitality | All other dissimilar constructs of legacy measures (n = 8) | Females will have higher fatigue scores than males; | 82% |
SSS-8 tiredness | Patients with CCI ≥ 3 will have higher fatigue scores than patients with CCI < 2 | |||
Sleep disturbance | SSS-8 sleep | All other dissimilar constructs of legacy measures (n = 9) | Females will have higher sleep disturbance scores than males | 91% |
Social roles | SF-12 SF | All other dissimilar constructs of legacy measures (n = 9) | Females will have lower social roles scores than males; Patients ages > 65 will have lower social roles scores than patients ages < 50; Patients with type A AD will have lower social roles scores than type B AD patients; Patients with CCI ≥ 3 will have lower social roles scores than patients with CCI < 2 | 86% |
Pain interference | SSS-8 pain | All other dissimilar constructs of legacy measures (n = 9) | Females will have higher pain interference scores than males | 91% |